ZIMMER BIOMET HOLDINGS, INC.

Key metrics

Financial performance

Over the last 9 fiscal years ZIMMER BIOMET HOLDINGS, INC.'s revenue grew from $7.67B to $8.23B, a compound annual growth rate of 0.8%. Net profit margin expanded from 4.0% to 8.6% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (1,000 filings)

Recent press releases

• Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 20262026-05-22

  WARSAW, Ind. , May 22, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2026. The cash dividend of $0.24 per share is payable on or about July 31, 2026 to stockholders of record as of the close of business on June 25, 2026.

• Zimmer Biomet Increases Share Repurchase Expectations -- Up to $1 Billion by Year End2026-05-12

  WARSAW, Ind. , May 12, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it now anticipates repurchasing up to $1 billion of its common stock during fiscal year 2026, a $250 million increase from the company's prior assumption.

• Zimmer Biomet to Present at the BofA Securities 2026 Health Care Conference2026-05-06

  WARSAW, Ind. , May 6, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Bank of America Securities Health Care Conference on Wednesday, May 13, 2026, with a fireside chat at 8:40 a.m. PT (11:40 a.m. ET).

• Zimmer Biomet Announces Chief Financial Officer Transition2026-04-28

  WARSAW, Ind. , April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced Suketu Upadhyay, Chief Financial Officer and Executive Vice President, Finance, Operations and Supply Chain, will depart the company effective April 28 for a new professional opportunity.

• Zimmer Biomet Announces First Quarter 2026 Financial Results2026-04-28

  WARSAW, Ind. , April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2026. The Company reported first quarter net sales of $2.087 billion, an increase of 9.3% over the prior year period, an increase of 6.8% on a constant currency 1 basis and an increase of 2.9% on an organic constant currency 1 basis. Net earnings for the first quarter were $238.1 million, or $409.4 million on an adjusted 1 basis.

Similar companies

The largest companies sharing ZIMMER BIOMET HOLDINGS, INC.'s SEC industry classification (orthopedic, prosthetic & surgical appliances & supplies).